author-photo

Yanan Guo

Brigham and Women's Hospital

11

Papers

436

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (0)
Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells

2014 Journal of Experimental Medicine
Show All
- Source
- Cite
- Save
Citations (61)
Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma

2014 Oncogene
Show All
- Source
- Cite
- Save
Citations (19)
Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer

2014 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (213)
Molecular Dissection of AKT Activation in Lung Cancer Cell Lines

2013 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (26)
Abstract C59: Estradiol and mTORC2 orchestrate to enhance prostaglandin biosynthesis andtumorigenesis in tuberous sclerosis complex

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Equivalent Benefit of Rapamycin and a Potent mTOR ATP-Competitive Inhibitor, MLN0128 (INK128), in a Mouse Model of Tuberous Sclerosis

2013 Molecular Cancer Research
- Yanan Guo
- David J. Kwiatkowski
Show All
- Source
- Cite
- Save
Citations (33)